Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

October 23, 2025 05:27 ET | Source: Silver Creek Pharmaceuticals, Inc.

Silver Creek Pharmaceuticals Announces Positive Phase 2 Results for Scp776 in Acute Ischemic Stroke

Silver Creek’s scp776 shows meaningful efficacy and safety in Phase 2 stroke trial, offering first potential therapy for late-window stroke patients.
October 17, 2025 10:41 ET | Source: Silver Creek Pharmaceuticals, Inc.

Silver Creek Pharmaceuticals Receives FDA Fast Track Designation for Scp776 in Acute Ischemic Stroke

Silver Creek Pharmaceutical's Scp776 earns FDA Fast Track designation for acute ischemic stroke